TransEnterix

Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System features a machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Durham, NC.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Asensus Surgical is a digital interface between the surgeon and patient to improve minimally invasive surgery through digital laparoscopy. They enable capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seek to address the current clinical, cognitive, and economic shortcomings in surgery.

TransEnterix is currently trading above $5. But does TRXC stock have what it takes to be the next Intuitive Surgical?

Don't Count on TransEnterix to Be the Next Intuitive Surgical

TransEnterix stock is up in trading today after a pair of big stock sales and ahead of its Feb. 23 Investor Day. The post TRXC Stock: Why TransEnterix Shares Are Soaring Today appeared first on InvestorPlace.

TRXC Stock: Why TransEnterix Shares Are Soaring Today

TRXC stock will do well over time, now that the company is well-capitalized. But does that mean it's a good time for new investors to hop on?

With $90 Million in Cash in the Bank, TransEnterix Should Survive

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will host a virtual Investor Day on February 23, 2021, beginning at 11:00am Eastern Time. “We are excited to provide an update on Senhance, including a deep dive into the technology and how we are positioning the system in Digital Laparoscopy. In additio

TransEnterix to Host Virtual Investor Day on February 23, 2021

CrowdStrike

One robotic surgery company and one cybersecurity specialist are bound to impress in the long run.

These 2 Growth Stocks Can Become Money Machines in the Next 5 Years

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing of its previously announced underwritten public offering of its common stock. Including the full exercise of the underwriter's option to purchase additional shares, the Company issued 26,545,832 shares at a public offering price of $3.00 per share. T

TransEnterix Announces Closing of $79.6 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares

Surgical robotics is a fascinating market niche with huge potential, and you can capitalize on its expansion with a position in TRXC stock. The post Hold TransEnterix Stock as This Tiny Company Has Big Potential appeared first on InvestorPlace.

Hold TransEnterix Stock as This Tiny Company Has Big Potential

Tellurian

Tilray Brands

Could there be more gains ahead for these recovering companies?

These 3 "Comeback Kid" Stocks Have Already Doubled in 2021

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 23,083,333 shares of common stock of the Company at a public offering price of $3

TransEnterix Increases Previously Announced Bought Deal Offering of Common Stock to $69.25 Million

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 8,333,334 shares of common stock of the Company at a public offerin

TransEnterix Announces $25.0 Million Bought Deal Offering of Common Stock

TransEnterix (TRXC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TransEnterix (TRXC) Upgraded to Buy: What Does It Mean for the Stock?

Does TransEnterix (TRXC) have what it takes to be a top stock pick for momentum investors? Let's find out.

What Makes TransEnterix (TRXC) a Strong Momentum Stock: Buy Now?

Conagra Brands

Earthstone Energy

GameStop

PROS Hlds

REV Group

Trinity Place Hlds

Insider trading can give outside investors valuable clues and insights. This includes both insider buying and selling.

7 Stocks With Clues From Insider Trading

The robotic surgery specialist is helping to enhance the capabilities of surgeons, but its shares may have come too far, too fast.

Why TransEnterix Stock Surged Today and Then Gave Up All its Gains

The stock price of Transenterix Inc (NYSEAMERICAN: TRXC) increased by 68.6% on Tuesday, January 19. This is why it happened.

TRXC Stock Price Increases 68.6%: Why It Happened

TransEnterix (TRXC) is seeing shares of TRXC stock soar higher on Tuesday following an update concerning its Intelligent Surgical Unit. The post TRXC Stock: 5 Things to Know About Surgical Robotics Play TransEnterix as Shares Soar appeared first on InvestorPlace.

TRXC Stock: 5 Things to Know About Surgical Robotics Play TransEnterix as Shares Soar

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company received CE Mark approval for the Intelligent Surgical UnitTM (ISUTM) that enables machine vision capabilities on the SenhanceⓇ Surgical System. This approval will provide Senhance digital laparoscopic programs in Europe access to this new technology

TransEnterix Receives CE Mark for Machine Vision System in Robotic Surgery

TransEnterix is developing a surgical robotic system to perform minimally invasive operations on the abdomen and pelvic region. The digital and AI-assisted system represents an alternative to current technologies on the market while addressing an unmet need in robotic-assisted surgery.

TransEnterix: Emerging Surgical Robotics Player With Bullish Momentum

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing of its previously announced registered direct offering of 25,000,000 shares of its common stock. The offering was priced at a purchase price per share of $1.25, for gross proceeds of approximately $31.25 million. TransEnterix intends to use the net p

TransEnterix Announces Closing of $31.25 Million Registered Direct Offering of Common Stock

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has entered into securities purchase agreements with several institutional investors for the purchase and sale, in a registered direct offering of 25,000,000 shares of its common stock at a purchase price of $1.25 per share for gross proceeds of $31.25 m

TransEnterix Announces $31.25 Million Registered Direct Offering of Common Stock

The stock price of Transenterix Inc (NYSEAMERICAN: TRXC) increased by 43.1% as it went from a previous close of $1.16 to $1.66 yesterday. This is why it happened.

TRXC Stock Price Increased 43.1%: Why It Happened

Digital laparoscopy play TRXC stock is on the move Monday. Here's what you should know about the company TransEnterix right now.

TRXC Stock: 14 Things for Investors to Know as TransEnterix Rockets Higher

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today provided a preliminary 2020 year-end corporate update. Recent Highlights Senhance® Surgical System received its registration certificate by the Russian medical device regulatory agency, Roszdravnadzor, allowing for its sale and utilization throughout the Russian Federatio

TransEnterix Provides Preliminary 2020 Year-End Corporate Update

As of late, it has definitely been a great time to be an investor in TransEnterix (TRXC).

TransEnterix's (TRXC) Shares March Higher, Can It Continue?

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at two upcoming virtual investor conferences: Presentation at the H.C. Wainwright BioConnect 2021 Conference available for on-demand listening beginning Monday, January 11, 2021, at 6:00 am Eastern Time. Digital Surgery Panel presentation at t

News for TransEnterix Stock (TRXC)